Literature DB >> 3124802

The mucopolysaccharidoses.

J E Wraith1, J G Rogers, D M Danks.   

Abstract

The experience of the Royal Children's Hospital in managing patients with mucopolysaccharidosis is discussed. All share the common feature of abnormal storage, within lysosomes, of partially degraded glycosaminoglycans, but different diseases within the group as a whole present different problems. The presentation, diagnosis and clinical outcome of 69 affected children are described.

Entities:  

Mesh:

Year:  1987        PMID: 3124802     DOI: 10.1111/j.1440-1754.1987.tb00284.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN: 0004-993X


  5 in total

Review 1.  Management of mucopolysaccharidosis type III.

Authors:  M A Cleary; J E Wraith
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

2.  Simultaneous occurrence of mucopolysaccharide type II disease (Hunter's syndrome) and systemic lupus erythematosus in a paediatric patient.

Authors:  A R Russell; M D Bain; R S Periera
Journal:  J R Soc Med       Date:  1992-02       Impact factor: 18.000

3.  Glycosaminoglycan storage disorders: a review.

Authors:  Maria Francisca Coutinho; Lúcia Lacerda; Sandra Alves
Journal:  Biochem Res Int       Date:  2011-10-05

4.  Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.

Authors:  Silvin Lito; Adama Sidibe; Sten Ilmjarv; Patricie Burda; Matthias Baumgartner; Bernhard Wehrle-Haller; Karl-Heinz Krause; Antoine Marteyn
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

Review 5.  Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions.

Authors:  Jeremy Wolfberg; Keerthana Chintalapati; Shunji Tomatsu; Kyoko Nagao
Journal:  Diagnostics (Basel)       Date:  2020-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.